Acusphere, Inc. (ACUS)

Market Cap	5.00
Revenue (ttm)	2.68M +0.6%
Net Income	-69.42M
EPS	-14.64
Shares Out	4.95M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	125
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.000001 - 0.0001
Beta	-0.45
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Acusphere

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUS

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 14, 2026

Data Sources Report a data error